VERSANT VENTURE CAPITAL VI, L.P. sold 99.1% of their position (550K shares) of OYSTER POINT PHARMA, INC. on the open market
Open‑market sale worth $8.16M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 10/20/2021ACC: 0000899243-21-040777
10% Owner
Since Oct 2019
-550K
Net shares
Net seller
$8.16M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
550K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−303.61K
Price / share
$14.63
Trade value
$4.44M
% of position
22.3%
10/18/2021
1.36M→1.06M
Common Stock
Indirect
Shares
−1.91K
Price / share
$14.63
Trade value
$27.98K
% of position
22.7%
10/18/2021
8.43K→6.52K
Common Stock
Indirect
Shares
−242.94K
Price / share
$15.09
Trade value
$3.67M
% of position
23.0%
10/18/2021
1.06M→815.03K
Common Stock
Indirect
Shares
−1.53K
Price / share
$15.09
Trade value
$23.11K
% of position
23.5%
10/18/2021
6.52K→4.99K
Total
Net shares
−550K
Net value
-$8.16M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/18/2021 | S · Sale | −303.61K | $14.63 | $4.44M | 22.3% | 1.36M | 1.06M |
| Common Stock Indirect | 10/18/2021 | S · Sale | −1.91K | $14.63 | $27.98K | 22.7% | 8.43K | 6.52K |
| Common Stock Indirect | 10/18/2021 | S · Sale | −242.94K | $15.09 | $3.67M | 23.0% | 1.06M | 815.03K |
| Common Stock Indirect | 10/18/2021 | S · Sale | −1.53K | $15.09 | $23.11K | 23.5% | 6.52K | 4.99K |
| Total | −550K | -$8.16M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1M
Common Stock
DirectShares owned2.24M
Total
2.24M direct·1M indirect3.24M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1M | Indirect |
| Common Stock | 2.24M | Direct |
| Total | 3.24M | 2.24M direct·1M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported